These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2906886)

  • 1. Acrivastine in seasonal allergic rhinitis: two randomized crossover studies to evaluate efficacy and safety.
    Gibbs TG; Irander K; Salo OP
    J Int Med Res; 1988; 16(6):413-9. PubMed ID: 2906886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ; Gibbs TG; Hellstern KH; Major EW; Mullinger B
    J Int Med Res; 1989; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G; D'Amato G; Del Giacco GS; Locci F; Gale NM; Errigo E; Melillo G
    J Int Med Res; 1989; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis.
    Gibbs TG; McDonnell KA; Stokes T; Graham AA
    Br J Clin Pract; 1989 Jan; 43(1):11-4. PubMed ID: 2574054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN; McTavish D
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P; Bruttman G; Pedrali P; Charpin J; Michel FB; Grilliat JP
    J Int Med Res; 1989; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis.
    Meran A; Morse J; Gibbs TG
    Rhinology; 1990 Mar; 28(1):33-40. PubMed ID: 1970907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
    Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
    Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed.
    Dockhorn RJ; Williams BO; Sanders RL
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):204-8. PubMed ID: 8595542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H; Fräki JE; Gibson JR
    Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrivastine/pseudoephedrine (Semprex-D) for seasonal allergic rhinitis.
    Med Lett Drugs Ther; 1994 Sep; 36(930):78-80. PubMed ID: 7914667
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J; Marks P; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled evaluation of Actifed and its individual constituents in allergic rhinitis.
    Connell JT; Williams BO; Allen S; Cato A; Perkins JG
    J Int Med Res; 1982; 10(5):341-7. PubMed ID: 6128282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.